Royal Bank of Canada
BIND

Royal Bank of Canada’s BIND THERAPEUTICS INC BIND Stock Holding History

Royal Bank of Canada’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-692
Closed – – 6855
2016
Q2 		$0 Buy
692
+292
+73% +$240 ﹤0.01% 6828
2016
Q1 		$1K Buy
+400
New +$725 ﹤0.01% 6293
2015
Q4 		– Sell
-764
Closed -$3K – 7234
2015
Q3 		$3K Hold
764
– – ﹤0.01% 6354
2015
Q2 		$4K Sell
764
-1,486
-66% -$9.21K ﹤0.01% 6302
2015
Q1 		$12K Hold
2,250
– – ﹤0.01% 5535
2014
Q4 		$12K Buy
2,250
+500
+29% +$3.75K ﹤0.01% 5567
2014
Q3 		$15K Buy
1,750
+1,461
+506% +$14.4K ﹤0.01% 5376
2014
Q2 		$4K Buy
289
+189
+189% +$1.85K ﹤0.01% 5644
2014
Q1 		$1K Buy
+100
New +$1.31K ﹤0.01% 5857

Royal Bank of Canada's BIND Position: Q3 2016 in Review

Royal Bank of Canada sold out of BIND THERAPEUTICS INC (BIND) in Q3 2016, closing a stake of 692 shares.

Royal Bank of Canada first reported a position in BIND in Q1 2014 and held it in 9 quarters. The position peaked at $15K in Q3 2014. 0 funds tracked by Wall St. Rank hold BIND as of Q3 2016.

  • Royal Bank of Canada reported no remaining BIND THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 692 BIND THERAPEUTICS INC shares in Q3 2016.
  • Royal Bank of Canada first reported a position in BIND THERAPEUTICS INC in Q1 2014 and held it in 9 quarters.
  • Royal Bank of Canada's BIND THERAPEUTICS INC position peaked at $15K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2016.

Based on Royal Bank of Canada's 13F filing for Q3 2016, filed 14 Nov 2016.